ABSTRACT
Refeeding Syndrome (RFS) is a potential life-threatening complication of the nutritional therapy in the replenishment phase after period of starvation. This not very known syndrome may be a life-threatening metabolic condition due to rapid, inadequate nutritional support in malnourished catabolic patients. The intake of food and therefore the switch from a catabolic to an anabolic metabolism is most considered etiological mechanism. The main biochemical feature of RFS is hypophosphatemia and low levels of potassium and magnesium. Lack of vitamins, especially vitamin B1 or thiamine is often present and involves severe clinical complications.
It is essential to know that the high morbidity and mortality can be reduced by early diagnosis and taking appropriate measures. Therefore, to be aware of this metabolic condition in critically ill patients is necessary for its prevention, recognition, and treatment. Despite many pathophysiological aspects of RFS remain unclear it is highly relevant to identify individuals at risk and avoid the development of RFS in the ICU. We insist on the need of electrolyte monitoring especially during the first 72 hours of initiation of nutritional support. Patients at risk may benefit from hypocaloric or restricted caloric intake for at least 48h resulting in lower long-term mortality.
RFS is common among critically ill patients. But the potential risk of RFS is poorly known. Future quality studies may help to as-sessment of RFS risk and optimize and standardize the RFS management.
Refeeding syndrome (RFS) is a potentially fatal acute metabolic derangement that can result in morbidity and mortality [1] . RFS is a potential life-threatening complication of the nutritional therapy in the replenishment phase after period of starvation [2] . From a pathophysiological point of view, the intake of food and therefore the switch from a catabolic to an anabolic metabolism is the main etiological mechanism.
By the start of the nutritional therapy, the concentration of glucose increases causing hyperglycemia and stimulates anabolic processes [2] . The increased insulin secretion causes the intracellular uptake of phosphate. In fact, the main biochemical feature of RFS is hypophosphatemia; and this abnormality is commonly encountered during critical illness [3] (4). Most commonly used definitions are based on hypophosphatemia [1] . The hypophosphatemia is usually accompanied by low concentrations of serum magnesium and potassium [1] [2] [5] . Rio et al. used a so-called three-facet criteria design to confirm the diagnosis of RFS unequivocally [6] . These criteria comprised disturbed electrolyte balances, acute peripheral edema or circulatory fluid overload combined with disturbances in organ function. Despite the exact pathophysiology of RFS remains unclear, mostly occurs because of the intracellular shift of glucose and electrolytes (phosphate, potassium, magnesium) occur, and their blood levels may drop severely provoking severe complications [7] [8] .
The hormonal and metabolic changes that occur in this syndrome are complex and may cause serious clinical complications [4] . Proteins, lipid and glucose metabolisms are disturbed, and a lack of vitamins, especially vitamin B1 (thiamine) occurs [2] . Thiamine deficiency thus may lead to Wernicke's encephalopathy or cardiovascular disorders with water retention [9] . Symptoms such as heart failure, peripheral edema, respiratory insufficiency, fluid imbalance and neurologic disorders can occur [2] [10]. If not treated, these disturbances can lead to severe negative effects, from multiorganic dysfunction to death [7] [8] .
RFS can be defined as the biochemical abnormalities and physical sings that occurs when a patient with vitamin and protein-energy malnutrition is incaustiously fed (whether enterally or parenterally) [11] . The lack of a proper uniform definition complicates diagnosis and research of RFS. Besides this, there is no clear correlations between risk factors proposed by international guidelines and the occurrence of RFS in ICU patients [3] . For this reason RFS and its relevance in critical illness remains unclear.
Recent literature shows that RFS is common among critically ill patients [1] [3] . But, whereas the awareness of malnutrition in the UCI is well established, the potential risk of RFS is much less known. Screening for RFS risk is not commonly done. Even when malnutrition is present, the risk of RFS is usually neglected or overlooked among hospitalized patients [2] [12] .
Concerning hospital stay and death the heterogeneous results in the different studies makes it difficult to establish a direct correlation between RFS and long-term outcomes [13] [14] . However, there is evidence that early diagnosis and adequate treatment may lead to better overall survival [1] . For this reason, it is highly relevant to identify individuals at risk and avoid the development of RFS in the ICU.
According to the guidelines of the National Institute for Health and Care Excellence the risk factors for RFS are: low BMI and/or unintentional weight loss within the last 6 months, a negligible food intake for more than 5 days, low electrolyte (phosphate, potassium, magnesium) levels prior to nutritional support, poor absorptive capacity, catabolism and chronic alcoholism [15] . Friedli N. et al. describe other risk factors as age (>70 years), low (pre)albumin or insulin-like growth factor, overfeeding, intravenous glucose infusion before nutritional support, or scoring at least 3 points on the nutritional risk screening [10] .
However, as common risk factors fail to identify RFS patients, regular phosphate and other electrolyte monitoring can be recommended at least once daily, in particular during the first 72h after the initiation of nutritional support [1] . In the review of Boot R. et al. it is recommended that if occurs a marked drop of phosphate levels (>0.16 mmol/l) from normal levels within 72h of commencement of feeding, that feature may select patients that benefit from hypocaloric or restricted caloric intake for at least 48h resulting in lower long-term mortality [1] . Friedli N. et al. suggests an interesting and detailed recommendations for the nutritional management according to all risk categories ( minor, high and very high risk) of developing RFS, including total caloric intake, fluid therapy, sodium restriction, thiamine and multivitamin supplement [10] . Given the small number of randomized studies the evidence is low; however, caloric restriction for several days and gradual increase of caloric intake over days is recommendable [3] .
Whereas if the RFS is yet established and diagnosed Boot R. et al. recommend as treatment strategy: electrolyte supplementation (phosphate, magnesium, potassium); glucose monitoring to prevent hypoglycemia and hyperglycemia; intravenous insulin administration in case of hyperglycemia; correction of fluid overload if necessary; thiamine supplementation at a minimum dose of 100 mg daily, for at least 7-10 days; restriction of total caloric intake to a maximum of 500kcal/24h during the first 48h after the diagnosis of refeeding hypophosphatemia and refeeding syndrome; gradually advance feeding after 48h of caloric restriction in daily steps of 25% of the target until the nutrition target is reached [1] .
It is essential to include the amount of non nutritional calories from propofol, citrate (renal replacement therapy) and intravenous carbohydrate solutions in total caloric intake calculations, because these may be even higher than the proposed cutoff for caloric restriction [16] .
In regard to elderly patients it is known that aging is often linked to frailty and poor nutritional status. Aubry E. et al. alert about the high risk for RFS in that kind of patients and recommend an early identification of patients and risk and a refeeding start at a low level of energy replacement [2] . As frailty is a reversible process and can be positively influenced by adequate nutritional support it is essential to optimize the nutritional therapy, especially in that population.
As conclusion, awareness of refeeding syndrome and identification of patients at risk is crucial as the condition is preventable and the metabolic complications are avoidable [4] . Despite the paucity of published guidance on the practical details of how refeeding patients at risk, most of authors recommend start at 10 kcal/kg/ day, increasing to full needs over a minimum of 4 days, with supplementation of thiamine, for at least 10 days, and regular phosphate and magnesium monitoring [11] [15] .
